Evidence map›Paper›PMID 32075693›Full record

ReviewJournal of medical case reports2020

Primary aldosteronism concurrent with subclinical Cushing's syndrome: a case report and review of the literature.

Yingxiao Zhang, Jianyu Tan, Qin Yang, Zhipeng Du, Shumin Yang, Wenwen He, Ying Song, Jinbo Hu, Yi Yang, Qifu Li and 4 more

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Journal of medical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Case Report: SomaticFrontiers in medicine · 2026
    Article
  4. Unrecognized primary aldosteronism may confound outcomes in adrenal Cushing's syndrome.Therapeutic advances in endocrinology and metabolism · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Primary Aldosteronism: State-of-the-Art Review.American journal of hypertension · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Yingxiao ZhangDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China.
Jianyu TanDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China.
Qin YangDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China.
Zhipeng DuDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China.
Shumin YangDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China.
Wenwen HeDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China.
Ying SongDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China.
Jinbo HuDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China.
Yi YangDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China.
Qifu LiDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China.
Yao ZhangDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China.
Yunfeng HeDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China.
Qingfeng ChengDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi St., Chongqing, 400016, China. cqf19760516@163.com.ORCID http://orcid.org/0000-0001-8676-5597
Chongqing Primary Aldosteronism Study (CONPASS) Group
The Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of primary aldosteronism concurrent with subclinical Cushing's syndrome was higher than previously thought. Through analyzing a rare clinical case, we summarized the diagnosis and management of primary aldosteronism with subclinical Cushing's syndrome. CASE PRESENTATION: A 54-year-old Chinese man of Han nationality was diagnosed as having primary aldosteronism with subclinical Cushing's syndrome. An abdominal computed tomography scan revealed a mass in his left adrenal gland and a mass in his right adrenal gland. After finishing sequential adrenal venous sampling without adrenocorticotropic hormone, the result reminded us that the left and right nodules were responsible for hypercortisolism and aldosterone hypersecretion, respectively. Right and left adrenalectomy were performed successively. The pathological diagnosis was adrenocortical adenoma for both. Histological findings revealed that the right one had positive immunostaining for CYP11B2 and the left one had positive immunostaining for CYP11B1. The immunohistochemistry result helped us to confirm the diagnosis. Somatic KCNJ5 mutation (Leu168Arg) was found in the right tumor; there was no KCNJ5 mutation in the left adrenal tumor.

conclusionsWe suggest that patients with primary aldosteronism should have a low-dose overnight dexamethasone suppression test to screen for hypercortisolism. It can help avoid misdiagnoses and contribute to proper understanding of the adrenal vein sampling result. Making sure of the nidus of aldosterone and cortisol secretion is crucial for the therapy of patients with primary aldosteronism and subclinical Cushing's syndrome.

Indexed as

AdrenalectomyAdrenal Gland NeoplasmsAdrenal GlandsAdrenocortical AdenomaChinaCushing SyndromeCytochrome P-450 CYP11B2G Protein-Coupled Inwardly-Rectifying Potassium ChannelsHumansHyperaldosteronismImmunohistochemistryMaleMiddle AgedSteroid 11-beta-HydroxylaseCytochrome P-450 CYP11B2G Protein-Coupled Inwardly-Rectifying Potassium ChannelsKCNJ5 protein, humanSteroid 11-beta-HydroxylaseAdrenal vein samplingPrimary aldosteronismSubclinical Cushing’s syndromeSubtype

Identifiers

PMID32075693
PMCPMC7031945
OpenAlexW3012772864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.